Resona Asset Management Co.,Ltd. Bristol Myers Squibb CO Transaction History
Resona Asset Management Co.,Ltd.
- $17 Billion
- Q1 2025
A detailed history of Resona Asset Management Co.,Ltd. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Resona Asset Management Co.,Ltd. holds 694,359 shares of BMY stock, worth $33.5 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
694,359
Previous 656,319
5.8%
Holding current value
$33.5 Million
Previous $37.1 Million
14.08%
% of portfolio
0.25%
Previous 0.22%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,809Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.24 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.66 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.22 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.58 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.21 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...